133 related articles for article (PubMed ID: 34036819)
21. Evaluation of a pharmacist-physician covisit model in a family medicine practice.
Ulrich IP; Patel S; Gilmer B
J Am Pharm Assoc (2003); 2019; 59(1):129-135. PubMed ID: 30416066
[TBL] [Abstract][Full Text] [Related]
22. Community and ambulatory pharmacy: evaluation of patient care services and billing patterns before implementation of Medicare part D.
Beatty SJ; Rodis JL; Bellebaum KL; Mehta BH
J Am Pharm Assoc (2003); 2006; 46(6):707-14. PubMed ID: 17176686
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the Efficacy of 3 Recruitment Methods for Enrolling Patients in Chronic Care Management Services: A Pilot Study.
Jenkins AB; Holley E; Rogers C; Montgomery N; Pate AN
Innov Pharm; 2022; 13(4):. PubMed ID: 37305605
[TBL] [Abstract][Full Text] [Related]
24. Pharmacist-Physician Split-Shared Visits in a Federally Qualified Health Center: Lessons Learned from a Novel Reimbursement Model using Telehealth.
Abou-Karam NM; Jump ME; Jiao J; Schmelz AN
Innov Pharm; 2022; 13(1):. PubMed ID: 36304686
[No Abstract] [Full Text] [Related]
25. Community Pharmacist and Family Medicine Collaboration for Pre-Visit Planning for Shared Patients Receiving Chronic Care Management Services.
Hoehns JD; Witry M; McDonald M; Kadura S; O'Brien E; Nichols R; Greenwood J; Snyder J; Chavez R; Froyum-Roise A
J Pharm Pract; 2024 Jun; 37(3):571-577. PubMed ID: 36592033
[No Abstract] [Full Text] [Related]
26. Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting.
Watkins JL; Landgraf A; Barnett CM; Michaud L
J Am Pharm Assoc (2003); 2012; 52(2):170-4. PubMed ID: 22370379
[TBL] [Abstract][Full Text] [Related]
27. PCImpact: A modeling tool for forecasting impact of primary care pharmacist services.
Mulrooney M; Smith M
Res Social Adm Pharm; 2021 Oct; 17(10):1810-1819. PubMed ID: 33685835
[TBL] [Abstract][Full Text] [Related]
28. Impact of a pharmacist in improving quality measures that affect payments to physicians.
Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
[TBL] [Abstract][Full Text] [Related]
29. Provision of pain management by a pharmacist with prescribing authority.
Dole EJ; Murawski MM; Adolphe AB; Aragon FD; Hochstadt B
Am J Health Syst Pharm; 2007 Jan; 64(1):85-9. PubMed ID: 17189585
[TBL] [Abstract][Full Text] [Related]
30. Current trends in outpatient pharmacy services and billing.
Beatty SJ; McCormick KM; Beale DJ; Bruggeman AM; Rodis JL; Mehta BH; Bennett MS
J Am Pharm Assoc (2003); 2012; 52(2):154-60. PubMed ID: 22370377
[TBL] [Abstract][Full Text] [Related]
31. Impact of quality measures performed through pharmacist collaboration with a primary care clinic.
Yon K; Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2020; 60(3S):S97-S102. PubMed ID: 32536482
[TBL] [Abstract][Full Text] [Related]
32. Development and economic evaluation of a pharmacist-provided chronic care management service in an ambulatory care geriatrics clinic.
Fixen DR; Linnebur SA; Parnes BL; Vejar MV; Vande Griend JP
Am J Health Syst Pharm; 2018 Nov; 75(22):1805-1811. PubMed ID: 30104259
[TBL] [Abstract][Full Text] [Related]
33. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
[TBL] [Abstract][Full Text] [Related]
34. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
Thomas MH; Goode JV
J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
[TBL] [Abstract][Full Text] [Related]
35. Billing for cognitive services: understanding Québec pharmacists' behavior.
Kröger E; Moisan J; Grégoire JP
Ann Pharmacother; 2000 Mar; 34(3):309-16. PubMed ID: 10917375
[TBL] [Abstract][Full Text] [Related]
36. Expanding oncology pharmacist teams: Justifying the return on investment.
Mahmoudjafari Z; Hough S
J Oncol Pharm Pract; 2022 Sep; 28(6):1381-1387. PubMed ID: 35274995
[TBL] [Abstract][Full Text] [Related]
37. Pharmacist medical provider status in Alaska, the last frontier.
Wadsworth TG; Hibbard A; Robinson R; Biddle MA; Nguyen E; O'Connor S; Paul A
J Am Pharm Assoc (2003); 2020; 60(6):e47-e51. PubMed ID: 32389554
[TBL] [Abstract][Full Text] [Related]
38. Pharmacists' impact on quality and financial metrics utilizing virtual care platforms during the coronavirus pandemic.
Glovacz JW; Betts SG; Cross S; Powell J
Am J Health Syst Pharm; 2022 May; 79(11):904-908. PubMed ID: 35136936
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.
Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA
J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two Medication Therapy Management Practice Models on Return on Investment.
Gazda NP; Berenbrok LA; Ferreri SP
J Pharm Pract; 2017 Jun; 30(3):282-285. PubMed ID: 26888260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
